| [1] |
WU Yujie, ZHAO Chengcheng, XI Qing.
Evaluation of tegacycline regimens in treatment of gram-negative bacterial infections with Monte Carlo simulation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1027-1033.
|
| [2] |
MAO Jun, RONG Yu, LI Yangen, XIONG Dengxi, ZHAO Peng, ZHA Zhengjiang.
Effect and safety of flurbiprofen axetil in the analgesic treatment of patients with craniocerebral injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1056-1060.
|
| [3] |
SU Yang, ZHOU Feng, DING Jinlei.
Effects of esketamine combined with sufentanil on postoperative analgesia and emotion after thoracoscopic radical resection of lung cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 59-65.
|
| [4] |
WANG Xin, SUN Heliang, ZHANG Qingwei, LIU Cunming, WANG Zhongyun, YANG Chun.
Postoperative analgesic effect of low-dose esketamine in patients with thoracoscopic lobectomy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 998-1003.
|
| [5] |
GU Yifei, CHU Nannan, HUANG Kai, QUE Linling, ZHANG Jisheng, XIANG Xuemei, HE Qing.
Application and progress of pharmacodynamics study in bioequivalence evaluation of orally inhaled drug products
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 822-833.
|
| [6] |
LI Yongliang, LIN Haiyan, ZHANG Lingling, DONG Yilong.
Effects of preoperative dezocine patient-controlled analgesia pump on stress response and cognitive function in elderly patients with lower extremity fractures
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 302-306.
|
| [7] |
ZHANG Jinhua, LIU Maobai, CAI Mingzhi, ZHENG Yingli, LAO Haiyan, XIANG Qian, DU Liping, ZHU Zhu, DONG Jing, ZUO Xiaocong, LI Xingang, SHANG Dewei, CHEN Bing, YE Yanrong, WANG Yuzhu, GAO Jianjun, ZHANG Jian, CHEN Wansheng, XIE Haitang, JIAO Zheng.
Model informed precision dosing of warfarin: China expert consensus report (2022 version)
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1201-1212.
|
| [8] |
WU Xiaoxia, ZHOU Hu.
Application of remifentanil in postoperative ICU sedation and analgesia in patients with severe craniocerebral trauma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1119-1124.
|
| [9] |
XU Liying, ZHANG Gaosong, HUANG Xiaomin, HUANG Jihan, WANG Shuhua.
Clinical efficacy and modeling evaluation of He-wei-zhi-xie capsules in treating diarrhea patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 47-55.
|
| [10] |
JIAO Zheng, LI Xingang, SHANG Dewei, DONG Jing, ZUO Xiaocong, CHEN Bing, LIU Jianmin, PAN Yan, ZHOU Tianyan, ZHANG Jing, LIU Dongyang, LI Lujin, FANG Yi, MA Guangli, DING Junjie, ZHAO Wei, CHEN Rui, XIANG Xiaoqiang, WANG Yuzhu, GAO Jianjun, XIE Haitang, HU Pei, ZHENG Qingshan.
Model informed precision dosing: China expert consensus report
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(11): 1215-1228.
|
| [11] |
LI Wenchao, BAI Xiangrong, LI Xiaoling, JIANG Dechun.
Population pharmacokinetics/pharmacodynamics of tigecycline in the treatment of different infectious diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(11): 1265-1272.
|
| [12] |
XIANG Rongfeng, SUN Fengjun, XIONG Lirong, YU Mingjie, DAI Qing, CHEN Yongchuan.
Pharmacokinetics and pharmacodynamics of (S)-pantoprazole sodium enteric-coated tablets in healthy subjects
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 903-909.
|
| [13] |
LI Jian, YANG Jinbo, WANG Yuzhu.
Applications of model-informed drug development (MIDD) on new drug research and development
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(1): 1-8.
|
| [14] |
ZHANG Shengpeng, MIU Dongdong, LIU Dingfeng, ZHU Xiaohong, ZHANG Chao, CHEN Yunyu, LIU Xiaoping.
Hepatic toxicity and pharmacodynamic effects of paracetamol and chlorphenamine maleate with three herb extracts capsules
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 489-495.
|
| [15] |
MA Guangli, XU Ling, CHEN Rui, CHEN Yuancheng, ZHAO Wei, LIU Dongyang, JIAO Zheng, LI Jian, JI Shuangmin, LI Li, LI Liang, WANG Yuzhu, YANG Jinbo, WANG Yaning, SUN He, HU Pei, ZHENG Qingshan, LU Wei.
General considerations of population pharmacokinetic/pharmacodynamic study in new drug development
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(11): 1201-1220.
|
